NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA
Published July 21, 2021 · Recall initiated: July 2, 2021
Summary
FDA records drug Class II recall D-0652-2021, published July 21, 2021 and initiated July 2, 2021. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 504 Cartons of 50 count each; 372 Cartons of 100 count each; Lot: Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if NIFEDIPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NIFEDIPINE
- Manufacturer
- The Harvard Drug Group
- Distributor
- Distributed in OH and NJ
- UPC
- 0309047080069
- Lot
- Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAB-Force, Homeopathic, 1 Fl Oz (30 mL) bottle, Distributed by: BioActive Nutritional, Inc., Melbourne, FLJuly 21, 2021
- FDAPoseidon Platinum 3500 capsule, 1-count per blister card, Distributed by: Poseidon, Made in the USA, UPC 0July 21, 2021
- FDADurisan Antimicrobial Solutions (benzalkonium chloride) Hand Sanitizer, listed as 0.1% or 0.13%, Alcohol-Free,July 21, 2021
- FDANonsterile Sterile Cesarean Birth Drape with Dual Layer Anesthesia Screen, Catalog Number 29442N - ProductJuly 14, 2021
- FDASterile Cesarean Birth Drape with Dual Layer Anesthesia Screen, Catalog Number 29442 - Product Usage: intendedJuly 14, 2021
- FDAVivorte Trabexus EB 10 cc Bone Void Filler -Fill bone and/or defect in skeletal system Model Number: 130703-10July 14, 2021
Questions about this recall
Was NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA recalled?
Yes. FDA published recall D-0652-2021 on July 21, 2021. Reported hazard: Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NIFEDIPINE. UPC: 0309047080069.